PATH EX, Inc.
PrivateLast Round
Series A
Apr 25, 2025
Total Funding Raised
$6.24M
Momentum Score
25 /100
Company Overview
PATH EX, Inc. is a medical device company developing CycloPE®, a blood purification device designed to directly capture and remove bacteria from the bloodstream to treat sepsis.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, Biotechnology, Clinical Trials
Business Model
B2B
Customer Profile
Hardware Sales, Government Contracts, Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
PATH EX, Inc. Comps
Public and private peers based on sector, stage, and business model.
PATH EX, Inc. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Apr 25, 2025 | ||||
| Grant | Oct 22, 2020 | ||||
| Grant | Jun 1, 2018 | ||||
| Grant | Jul 1, 2017 |
Key People
Founding team and executive leadership
PATH EX, Inc. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| IAG Capital Partners | Series A |
| MassChallenge | Grant |
| Fitz Gate Ventures | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Apr 17, 2026
Monthly visitors increased 152% MoM, reaching 1K.
PATH EX, Inc. Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about PATH EX, Inc.'s valuation, stock price, and market status.
